Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Danvilostomig by Systimmune for Gastric Cancer: Likelihood of Approval
Danvilostomig is under clinical development by Systimmune and currently in Phase II for Gastric Cancer. According to GlobalData, Phase II...
Danvilostomig by Systimmune for Epithelial Ovarian Cancer: Likelihood of Approval
Danvilostomig is under clinical development by Systimmune and currently in Phase II for Epithelial Ovarian Cancer. According to GlobalData, Phase...
Danvilostomig by Systimmune for Endometrial Cancer: Likelihood of Approval
Danvilostomig is under clinical development by Systimmune and currently in Phase II for Endometrial Cancer. According to GlobalData, Phase II...
Danvilostomig by Systimmune for Fallopian Tube Cancer: Likelihood of Approval
Danvilostomig is under clinical development by Systimmune and currently in Phase II for Fallopian Tube Cancer. According to GlobalData, Phase...
Danvilostomig by Systimmune for Peritoneal Cancer: Likelihood of Approval
Danvilostomig is under clinical development by Systimmune and currently in Phase II for Peritoneal Cancer. According to GlobalData, Phase II...
Danvilostomig by Systimmune for Nasopharyngeal Cancer: Likelihood of Approval
Danvilostomig is under clinical development by Systimmune and currently in Phase II for Nasopharyngeal Cancer. According to GlobalData, Phase II...
Danvilostomig by Systimmune for Gastrointestinal Tumor: Likelihood of Approval
Danvilostomig is under clinical development by Systimmune and currently in Phase II for Gastrointestinal Tumor. According to GlobalData, Phase II...
Danvilostomig by Systimmune for Metastatic Colorectal Cancer: Likelihood of Approval
Danvilostomig is under clinical development by Systimmune and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData, Phase...
Danvilostomig by Systimmune for Esophageal Cancer: Likelihood of Approval
Danvilostomig is under clinical development by Systimmune and currently in Phase II for Esophageal Cancer. According to GlobalData, Phase II...